Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05292534 · ClinicalTrials.gov registry record · NA
Evaluation of the Clinical Benefit of the Hearing Aids Tinnitus Feature.
A NA study, sponsored by Sonova.
- Completed
- Registry status
- NA
- Development phase
- 38
- Enrollment target
NCT05292534 is a NA study that has completed, run by Sonova. The registered enrollment target is 38 participants.
The verdict
NCT05292534, a NA study, has completed, sponsored by Sonova.
- COMPLETED
- Registry status
- NA
- Development phase
- 38 participants
- Enrollment target
Study Summary
Participants with hearing loss and Tinnitus will wear hearing aids with amplification-only or with an added sound, and have their tinnitus level evaluated before and after intervention.
Interventions
- DEVICE hearing aid amplification
- DEVICE hearing aid amplification with an added sound
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2022-06-01 |
| Est. Completion | 2023-09-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05292534
The ClinicalTrials.gov registry entry for NCT05292534 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sonova, which has 29 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which hearing aid amplification is the first listed.
NCT05292534 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05292534 about?
NCT05292534 is a clinical study titled "Evaluation of the Clinical Benefit of the Hearing Aids Tinnitus Feature.". Participants with hearing loss and Tinnitus will wear hearing aids with amplification-only or with an added sound, and have their tinnitus level evaluated before and after intervention.
What is the current status of trial NCT05292534?
This trial is currently completed. It is a NA study. The enrollment target is 38 participants. The study started on 2022-06-01. Estimated completion is 2023-09-20.
What interventions are being tested in trial NCT05292534?
The interventions under investigation include: hearing aid amplification (DEVICE), hearing aid amplification with an added sound (DEVICE).
Who is sponsoring clinical trial NCT05292534?
This trial is sponsored by Sonova, which has 29 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.